Contact
searchSearch
HMP Global
Industry Posters

TrenibotulinumtoxinE Rapidly Improves Moderate to Severe Glabellar Lines: Pooled Phase 3 Efficacy and Safety Across East Asian and North American/European Trials

Music City SCALE 2026

Steve Dayan, Mana Hirayama, Shu-Hung Huang, Edward Lain, Marion Moers-Carpi, Jiaming Sun, Hongyi Zhao, Chung-Yi C. Chiang, Ziyang Liu, Grace S. Park, Amy S. Weitzenfeld, Yoko Yajima, Joan-En Chang-Lin

This browser does not support PDFs. Please download the PDF to view it: Download PDF.

Popular Articles

Alopecia Areata, blad head
FDA Alerts
Deuruxolitinib FDA Approved for Severe Alopecia Areata in Adults
07/30/2024
Riya Gandhi, MA
The FDA has approved deuruxolitinib (LEQSELVI) 8 mg tablets for the treatment of adults with severe alopecia areata, a condition affecting approximately 300,000 individuals in the United States.
The FDA has approved deuruxolitinib (LEQSELVI) 8 mg tablets for the treatment of adults with severe alopecia areata, a condition affecting approximately 300,000 individuals in the United States.
The FDA has approved...
07/30/2024
The Dermatologist
psoriatic arthritis
News
Nutritional Effect on Lipoproteins Associated With Psoriatic Arthritis
09/11/2024
Jessica Garlewicz
This study aimed to evaluate the effects of a 12-week nutritional intervention on high-density lipoprotein and low-density lipoprotein cholesterol levels and their subfractions in patients with psoriatic arthritis.
This study aimed to evaluate the effects of a 12-week nutritional intervention on high-density lipoprotein and low-density lipoprotein cholesterol levels and their subfractions in patients with psoriatic arthritis.
This study aimed to evaluate the...
09/11/2024
The Dermatologist
Derm Dx
What Caused This Blister on the Hand?
08/07/2024
Aamir N. Hussain, MD, MAPP
A healthy 3-month-old male infant was brought in by his mother for evaluation of a recurrent blister on his right dorsal hand.
A healthy 3-month-old male infant was brought in by his mother for evaluation of a recurrent blister on his right dorsal hand.
A healthy 3-month-old male...
08/07/2024
The Dermatologist
Chief Medical Editor Message
The Microbiome
10/06/2024
Steven R. Feldman, MD, PhD
Dermatology and our patients have benefited greatly from scientific advances over the past decades.
Dermatology and our patients have benefited greatly from scientific advances over the past decades.
Dermatology and our patients...
10/06/2024
The Dermatologist
psoriatic arthritis
News
Global and Regional Epidemiology of Psoriatic Arthritis in Patients With Psoriasis
06/26/2024
Jessica Garlewicz
Researchers comprehensively analyzed global epidemiologic data on psoriatic arthritis (PsA) among patients with psoriasis.
Researchers comprehensively analyzed global epidemiologic data on psoriatic arthritis (PsA) among patients with psoriasis.
Researchers comprehensively...
06/26/2024
The Dermatologist
June 2026 issue

Current Issue

June 2026
Volume 34
Issue 4
Current Issue
Issue Archive

Latest Quizzes and Trivia

Quiz
Type 2 Endotypes and Therapeutic Strategy in Prurigo Nodularis
06/25/2026
Riya Gandhi, MA
Assess advanced concepts in type 2 inflammatory endotypes, shared therapeutic pathways, and practical treatment approaches in prurigo nodularis.
Assess advanced concepts in type 2 inflammatory endotypes, shared therapeutic pathways, and practical treatment approaches in prurigo nodularis.
Assess advanced concepts in type...
06/25/2026
The Dermatologist
itch
Quiz
Fibrosis and Persistent Itch in Prurigo Nodularis
06/15/2026
Riya Gandhi, MA
Test your clinical understanding of fibrotic remodeling and the mechanisms underlying persistent itch and chronic disease activity in prurigo nodularis.
Test your clinical understanding of fibrotic remodeling and the mechanisms underlying persistent itch and chronic disease activity in prurigo nodularis.
Test your clinical understanding...
06/15/2026
The Dermatologist
brain
Quiz
Neuroimmune Mechanisms and Cytokine Signaling in Prurigo Nodularis
06/05/2026
Riya Gandhi, MA
Explore advanced concepts in neuroimmune communication, cytokine-driven itch amplification, and fibrotic signaling pathways involved in prurigo nodularis.
Explore advanced concepts in neuroimmune communication, cytokine-driven itch amplification, and fibrotic signaling pathways involved in prurigo nodularis.
Explore advanced concepts in...
06/05/2026
The Dermatologist
Quiz
Predicting Disease Severity and Persistence in Pediatric Atopic Dermatitis
04/15/2026
Riya Gandhi, MA
Test your expertise in identifying risk factors for persistent pediatric atopic dermatitis and understanding the interplay between barrier dysfunction and immune dysregulation.
Test your expertise in identifying risk factors for persistent pediatric atopic dermatitis and understanding the interplay between barrier dysfunction and immune dysregulation.
Test your expertise in...
04/15/2026
The Dermatologist
Quiz
Type 2 Inflammation and Early Systemic Therapy in Pediatric Atopic Dermatitis
04/05/2026
Riya Gandhi, MA
Assess advanced clinical reasoning in pediatric atopic dermatitis, including implications of type 2 inflammation for diagnosis, treatment timing, and systemic therapy decisions.
Assess advanced clinical reasoning in pediatric atopic dermatitis, including implications of type 2 inflammation for diagnosis, treatment timing, and systemic therapy decisions.
Assess advanced clinical...
04/05/2026
The Dermatologist
Quiz
Disease Heterogeneity in PN
03/15/2026
Riya Gandhi, MA
Challenge your understanding of direct and indirect cytokine–nerve interactions and mechanical hypersensitivity of type 2 signaling in prurigo nodularis.
Challenge your understanding of direct and indirect cytokine–nerve interactions and mechanical hypersensitivity of type 2 signaling in prurigo nodularis.
Challenge your understanding of...
03/15/2026
The Dermatologist
Quiz
Rethinking Severity and JAK Inhibitor Strategy in Alopecia Areata
03/12/2026
Riya Gandhi, MA
How should clinicians redefine severe alopecia areata? When is it appropriate to treat ≤20% scalp involvement with oral JAK inhibitors? This expert-level quiz explores remission durability, treatment withdrawal, and practical strategies for...
How should clinicians redefine severe alopecia areata? When is it appropriate to treat ≤20% scalp involvement with oral JAK inhibitors? This expert-level quiz explores remission durability, treatment withdrawal, and practical strategies for...
How should clinicians redefine...
03/12/2026
The Dermatologist
Quiz
Cytokine Hierarchy and Sustained Pruritus in PN
03/10/2026
Riya Gandhi, MA
Explore the hierarchical and cooperative roles of IL-4, IL-13, and IL-31 in sustaining chronic itch and inflammation in prurigo nodularis.
Explore the hierarchical and cooperative roles of IL-4, IL-13, and IL-31 in sustaining chronic itch and inflammation in prurigo nodularis.
Explore the hierarchical and...
03/10/2026
The Dermatologist
Quiz
Type 2 Inflammation as a Pathogenic Driver in Prurigo Nodularis
03/05/2026
Riya Gandhi, MA
Test your understanding of how type 2 immune signaling drives chronic itch in prurigo nodularis through complex neuroimmune interactions.
Test your understanding of how type 2 immune signaling drives chronic itch in prurigo nodularis through complex neuroimmune interactions.
Test your understanding of how...
03/05/2026
The Dermatologist
psoriasis
Quiz
Distinguishing Feature of Generalized Pustular Psoriasis
03/02/2026
Jessica Garlewicz
What is a key distinguishing feature of generalized pustular psoriasis that differentiates it from plaque psoriasis?
What is a key distinguishing feature of generalized pustular psoriasis that differentiates it from plaque psoriasis?
What is a key distinguishing...
03/02/2026
The Dermatologist

HMP Global Products

Events

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2026 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Terms of Use